ArticleBiomaterials2016
Targeted multimodal nano-reporters for pre-procedural MRI and intra-operative image-guidance.
Open access · bronzeAbstract read
In one paragraph
Article in Biomaterials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 50 citations in OpenAlex.
- Advances in nanorobotics for gastrointestinal surgery: a new frontier in precision medicine and minimally invasive therapeutics.Journal of robotic surgery · 2025Review
- Photothermal applications of upconversion nanoparticles.RSC advances · 2025Review
- Engineered upconversion nanoparticles for breast cancer theranostics.Theranostics · 2025Review
- Research progress of nanoparticles in diagnosis and treatment of hepatocellular carcinoma.Open life sciences · 2024Review
- Multifunctional nanoplatforms application in the transcatheter chemoembolization against hepatocellular carcinoma.Journal of nanobiotechnology · 2023Review
- Iron-Based Hollow Nanoplatforms for Cancer Imaging and Theranostics.Nanomaterials (Basel, Switzerland) · 2022Review
- Nanotechnology in the Diagnostic and Therapy of Hepatocellular Carcinoma.Materials (Basel, Switzerland) · 2022Review
- Targeted Molecular Imaging Probes Based on Magnetic Resonance Imaging for Hepatocellular Carcinoma Diagnosis and Treatment.Biosensors · 2022Review
- Advanced Magnetic Resonance Imaging (MRI) Techniques: Technical Principles and Applications in Nanomedicine.Cancers · 2022Review
- Low-temperature open-air synthesis of PVP-coated NaYFRoyal Society open science · 2022Article
- Progresses in Fluorescence Imaging Guidance for Bone and Soft Tissue Sarcoma Surgery.Frontiers in oncology · 2022Review
- Multifunctional Nanocarriers-Mediated Synergistic Combination of Immune Checkpoint Inhibitor Cancer Immunotherapy and Interventional Oncology Therapy.Advanced nanobiomed research · 2021Article
- Artificially engineered antiferromagnetic nanoprobes for ultra-sensitive histopathological level magnetic resonance imaging.Nature communications · 2021Article
- Tailor-Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021Review
- Sodium Cholate Bile Acid-Stabilized Ferumoxytol-Doxorubicin-Lipiodol Emulsion for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma.Journal of vascular and interventional radiology : JVIR · 2020Article
- Tumor Microenvironment Targeting Nano-Bio Emulsion for Synergistic Combinational X-Ray PDT with Oncolytic Bacteria Therapy.Advanced healthcare materials · 2020Article
- An NIR-II/MR dual modal nanoprobe for liver cancer imaging.Nanoscale · 2020Article
- Methods of Granulocyte Isolation from Human Blood and Labeling with Multimodal Superparamagnetic Iron Oxide Nanoparticles.Molecules (Basel, Switzerland) · 2020Article
- Factors impacting technical success rate of image-guided intra-arterial therapy in rat orthotopic liver tumor model.American journal of translational research · 2019Article
- Photoperiodic Flower Mimicking Metallic Nanoparticles for Image-Guided Medicine Applications.ACS applied materials & interfaces · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 1 country.
Joonseok LeeCenter for Nanoscale Materials, Argonne National Laboratory, Argonne, IL 60439, USA.
Andrew C GordonDepartment of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Department of Biomedical Engineering, Northwestern University, Evanston, IL 60208, USA.
Hacksung KimDepartment of Chemistry, Northwestern University, Evanston, IL 60208, USA.
Wooram ParkDepartment of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Soojeong ChoDepartment of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Byeongdu LeeAdvanced Photon Source, Argonne National Laboratory, Argonne, IL 60439, USA.
Andrew C LarsonDepartment of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL 60611, USA; Department of Biomedical Engineering, Northwestern University, Evanston, IL 60208, USA; Department of Electrical Engineering and Computer Science, Evanston, IL 60208, USA; International Institute of Nanotechnology (IIN), Northwestern University, Evanston, IL 60208, USA.
Elena A RozhkovaCenter for Nanoscale Materials, Argonne National Laboratory, Argonne, IL 60439, USA. Electronic address: rozhkova@anl.gov.
Dong-Hyun KimDepartment of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL 60611, USA. Electronic address: dhkim@northwestern.edu.
Northwestern University · USArgonne National Laboratory · US
Funding
Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9MNorthwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8MMEDICAL SCIENTIST TRAINING PROGRAMT32GM008152 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ARDEHALI, HOSSEIN · 1987 to 2021
$24.0MMRI of Iron-labeled Microsphere Biodistribution for Radioembolization DosimetryR01CA141047 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LARSON, ANDREW CHRISTIAN · 2010 to 2013
$1.2MMagnetic Nanocomposites for Catheter-Directed Drug Delivery to Liver TumorsR21EB017986 · NIBIB · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KIM, DONG-HYUN · 2014 to 2015
$425kMagnetic Micelles for Catheter-Directed Sorafenib Delivery to Liver TumorsR21CA185274 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KIM, DONG-HYUN · 2015 to 2016
$367kTargeted Transcatheter Magneto-Mechanical Therapy for Hepatocellular CarcinomaR21CA173491 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KIM, DONG-HYUN · 2013 to 2014
$364kNCATS NIH HHS UL1 TR001422NCI NIH HHS P30 CA060553NCI NIH HHS R01 CA141047NCI NIH HHS R21 CA173491NCI NIH HHS R21 CA185274NIBIB NIH HHS R21 EB017986NIGMS NIH HHS T32 GM008152
Abstract
Multimodal-imaging probes offer a novel approach, which can provide detail diagnostic information for the planning of image-guided therapies in clinical practice. Here we report targeted multimodal Nd
Indexed as
AnimalsCarcinoma, HepatocellularCell LineCell SurvivalContrast MediaFluorescent DyesHumansInfusions, Intra-ArterialIntraoperative PeriodLiverLiver NeoplasmsMagnetic Resonance ImagingMaleMultimodal ImagingNanoparticlesNeodymiumContrast MediaFluorescent DyesNeodymiumCancerInterventional radiologyMedical imagingMultimodal probeUpconversion nanoparticles
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.